Provided by Tiger Fintech (Singapore) Pte. Ltd.

Illumina

97.93
+0.97001.00%
Post-market: 97.50-0.4300-0.44%19:48 EDT
Volume:1.94M
Turnover:188.96M
Market Cap:15.50B
PE:-16.11
High:98.41
Open:96.80
Low:96.17
Close:96.96
Loading ...

Illumina Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
02 May

Illumina Partners With Ovation.io to Create GLP-1 Dataset for Drug Discovery

MT Newswires Live
·
01 May

Illumina (ILMN) Earnings Expected to Grow: Should You Buy?

Zacks
·
01 May

Illumina and Ovation.IO Launching First-of-Kind Glp-1 Dataset to Accelerate New Therapy Development

THOMSON REUTERS
·
01 May

Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development

PR Newswire
·
01 May

Even after rising 3.7% this past week, Illumina (NASDAQ:ILMN) shareholders are still down 74% over the past five years

Simply Wall St.
·
30 Apr

Illumina price target lowered to $92 from $115 at Canaccord

TIPRANKS
·
29 Apr

Illumina Inc. Stock Rises Thursday, Still Underperforms Market

Dow Jones
·
25 Apr

Should You Hold Illumina (ILMN)?

Insider Monkey
·
24 Apr

Piper Sandler Reaffirms Their Buy Rating on Illumina (ILMN)

TIPRANKS
·
23 Apr

Illumina Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
22 Apr

This Cancer Test Could Become Routine -- and a Big Seller, Says Analyst -- Barrons.com

Dow Jones
·
22 Apr

Illumina Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
17 Apr

Illumina price target lowered to $90 from $130 at Bernstein

TIPRANKS
·
16 Apr

BRIEF-Illumina And Tempus Partner To Drive The Future Of Precision Medicine Through Genomic Ai Innovation

Reuters
·
15 Apr

Illumina and Tempus Partner to Drive the Future of Precision Medicine Through Genomic AI Innovation

THOMSON REUTERS
·
15 Apr

Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation

PR Newswire
·
15 Apr

Top Analyst Reports for Bank of America, Chevron & Stryker

Zacks
·
15 Apr

Life Sciences Companies Likely to See Surprisingly Good 1Q Results -- Market Talk

Dow Jones
·
15 Apr

BofA Securities Cuts Price Target on Illumina to $75 From $90, Keeps Underperform Rating

MT Newswires Live
·
14 Apr